TORONTO--(BUSINESS WIRE)--Axela Inc., a recognized innovator in protein interaction technology, and researchers from the Johns Hopkins University School of Medicine, presented initial work illustrating the novel ability of the dotLabTM System to measure Cardiac Troponin Complexes at the US HUPO meeting in Bethesda, Maryland. The presentation entitled, Development of a novel diffraction-based immunoassay for characterizing the primary and ternary structure of the circulating form of cardiac Troponin, is authored by Dr. Qin Fu and Dr. Jennifer E. Van Eyk, both of the Johns Hopkins University School of Medicine, and Dr. Yixin Lin of Axela. Dr. Van Eyk, is the Director of the Johns Hopkins NHLBI Proteomics Center in Baltimore, U.S.A. The JHNBPC uses the latest technologies to search for proteins that are key predictors of heart, lung and blood diseases.
